66
Views
5
CrossRef citations to date
0
Altmetric
Original Research

A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab

, , , , , , , & show all
Pages 33-40 | Published online: 23 Dec 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (5)